SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
GlaxoSmithKline Antibody Drug Combats Rare Blood Disorder, Cincinnati Children’s Hospital Medical Center Study
March 17, 2008
 · 
1 min read
Drug Development
Ibuprofen Destroys Aspirin’s Positive Effect On Stroke Risk, University at Buffalo Study Shows
March 17, 2008
 · 
1 min read
Drug Development
Don’t Prescribe Antibiotics For Adult Sinus Woes, University Hospital Basel Study
March 14, 2008
 · 
1 min read
Drug Development
Vitamin D Pills May Protect Kids From Type-1 Diabetes, St Mary’s Hospital for Women and Children Study
March 13, 2008
 · 
1 min read
Drug Development
Aspirin Use May Prevent Asthma, Harvard Medical School Study Finds
March 13, 2008
 · 
1 min read
Drug Development
Mount Sinai Hospital in Toronto Doctors See How Cancer Drug Avastin Can Damage Kidneys
March 13, 2008
 · 
1 min read
Drug Development
Second Study Finds Treating Herpes Won’t Stop HIV, London School of Hygiene and Tropical Medicine Study
March 13, 2008
 · 
1 min read
Drug Development
Researchers Find Cause of Severe Allergic Reaction to Cancer Drug, National Institute of Allergy And Infectious Diseases (NIAID) Study
March 13, 2008
 · 
1 min read
Drug Development
Body Building Pill May Prevent Baby Brain Damage, Monash University Study
March 12, 2008
 · 
1 min read
Drug Development
Certain Oral Contraceptives May Pose Health Risks, University of Oregon Study Suggests
March 12, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
New Epidemiological Data Provide Additional Safety Evidence for Sanofi (France)'s Lantus(R)
June 12, 2012
 · 
13 min read
Drug Development
Sanofi (France)'s Lantus Shows No Cancer, Heart Risks: Study
June 12, 2012
 · 
11 min read
Drug Development
GlaxoSmithKline’s Avandia and University of Nottingham’s Actos are Linked to Vision Problems
June 12, 2012
 · 
1 min read
Drug Development
Ampio Pharmaceuticals, Inc. Release: Announces Positive Clinical Trial Results for the Treatment of Diabetic Macular Edema with Orally Administered Optina(TM)
June 11, 2012
 · 
6 min read
Drug Development
Sanofi (France) Release: Lyxumia® (lixisenatide) in Combination with Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
June 11, 2012
 · 
9 min read
Drug Development
Halozyme Therapeutics, Inc. Release: Interim Data From Pre-administration of Hylenex in Analog Insulin Pump Therapy Demonstrate Consistent Insulin Action Profile: Data Presented in Late-Breaker Poster at American Diabetes Association 2012
June 11, 2012
 · 
5 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients With Type 2 Diabetes
June 11, 2012
 · 
1 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: BYETTA® Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
June 11, 2012
 · 
1 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: Once-Weekly BYDUREON™ Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
June 11, 2012
 · 
1 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: BYDUREON™ Was Associated With Significant and Sustained Glycemic Control at Four Years
June 11, 2012
 · 
1 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: SYMLIN® Use Helped Patients With Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
June 11, 2012
 · 
1 min read
Drug Development
Sanofi (France)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc.'s Januvia
June 11, 2012
 · 
1 min read
Drug Development
Novo Nordisk A/S Says Victoza Superior to Amylin Pharmaceuticals, Inc. Rival
June 11, 2012
 · 
1 min read
Drug Development
Data From Follow-Up Study of Vertex Pharmaceuticals Incorporated’ KALYDECO™ (ivacaftor) Showed Durable Improvements in Lung Function and Other Measures of Disease in People With Cystic Fibrosis Who Have a Specific Genetic Mutation (G551D)
June 8, 2012
 · 
11 min read
Drug Development
Amgen Drug Sensipar Fails to Meet Trial Goal
June 8, 2012
 · 
10 min read
Drug Development
Boehringer Ingelheim Corporation Release: FDA Affirms Superiority of Pradaxa® (dabigatran etexilate) 150 Mg Over Warfarin in Reduction of Both Ischaemic and Haemorrhagic Strokes
June 6, 2012
 · 
1 min read
Drug Development
Roche’s Actemra Beats Abbott Laboratories Drug in RA Trial
June 6, 2012
 · 
7 min read
Drug Development
Bristol-Myers Squibb Company Presents New 4-Year Data from the Long-Term Extensions of the BENEFIT and BENEFIT-EXT Clinical Trials of NULOJIX®(belatacept)
June 5, 2012
 · 
1 min read
Drug Development
Should the Johnson & Johnson Zytiga Trial Have Ended Early?
June 5, 2012
 · 
1 min read
Drug Development
Johnson & Johnson Prostate Cancer Drug So Effective Trial Stopped
June 4, 2012
 · 
1 min read
Load More